Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab.
- DOI
- 10.1212/nxi.0000000000200349
- Published
- 2025 Jan
- Container
- Neurology(R) neuroimmunology & neuroinflammation
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1212/nxi.0000000000200349,
title = {Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab.},
author = {Vukusic S and Bove R and Dobson R and McElrath T and Oreja-Guevara C and Pietrasanta C and Lin CJ and Ferreira G and Craveiro L and Zecevic D and Pasquarelli N and Hellwig K},
year = {2025},
journal = {Neurology(R) neuroimmunology \& neuroinflammation},
doi = {10.1212/nxi.0000000000200349},
url = {https://doi.org/10.1212/nxi.0000000000200349}
}RIS
TY - JOUR TI - Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab. AU - Vukusic S AU - Bove R AU - Dobson R AU - McElrath T AU - Oreja-Guevara C AU - Pietrasanta C AU - Lin CJ AU - Ferreira G AU - Craveiro L AU - Zecevic D AU - Pasquarelli N AU - Hellwig K PY - 2025 JO - Neurology(R) neuroimmunology & neuroinflammation DO - 10.1212/nxi.0000000000200349 UR - https://doi.org/10.1212/nxi.0000000000200349 ER -
APA
S, V., R, B., R, D., T, M., C, O., C, P., CJ, L., G, F., L, C., D, Z., N, P., & K, H. (2025). Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab.. Neurology(R) neuroimmunology & neuroinflammation. https://doi.org/10.1212/nxi.0000000000200349
Source records
- pubmed · retrieved 2026-11-10T04:46:49.156Z
- europe-pmc · retrieved 2026-11-10T04:46:49.175Z